{"id":362698,"date":"2023-11-28T07:47:07","date_gmt":"2023-11-28T12:47:07","guid":{"rendered":"https:\/\/platohealth.ai\/new-covid-variant-takes-hold-in-the-united-states-drugs-com-mednews\/"},"modified":"2023-11-28T12:24:38","modified_gmt":"2023-11-28T17:24:38","slug":"new-covid-variant-takes-hold-in-the-united-states-drugs-com-mednews","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/new-covid-variant-takes-hold-in-the-united-states-drugs-com-mednews\/","title":{"rendered":"New COVID Variant Takes Hold in the United States – Drugs.com MedNews","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
Medically reviewed by Carmen Pope, BPharm<\/a>. Last updated on Nov 28, 2023.<\/span><\/p>\n By Robin Foster HealthDay Reporter<\/p>\n TUESDAY, Nov. 28, 2023 (Healthday News) — The prevalence of a highly mutated COVID variant has tripled in the past two weeks, new government data shows.<\/p>\n Now, nearly 1 in 10 new COVID cases are fueled by the BA.2.86 variant, the U.S. Centers for Disease Control and Prevention reported<\/a><\/ins> Monday.<\/p>\n The variant is spreading the fastest in the Northeast: Just over 13% of cases in the New York and New Jersey region are blamed on BA.2.86.<\/p>\n Scientists first warned<\/a> of the highly mutated variant back in August, but it has since spread in several regions of the United States.<\/p>\n Until now, the vast majority of new COVID cases have been blamed on the XBB variant and several of its descendants, including the HV.1 and EG.5 variants.<\/p>\n But that may soon change.<\/p>\n The CDC’s estimates carry wide margins of error around BA.2.86’s prevalence, but the latest estimate is triple what it was on Nov. 11, the data showed.<\/p>\n Still, “it is important to note that early projections tend to be less reliable, since they depend on examining growth trends of a smaller number of sequences, especially as laboratory-based testing volume for SARS-CoV-2 has decreased substantially over time,” the agency noted in an update<\/a> on the variant.<\/p>\n So far, preliminary data on the variant suggests it does not trigger more severe illness than previous variants, the WHO said in a recent risk evaluation<\/a><\/ins>, but the international agency still noted a recent and “substantial rise” in BA.2.86 cases.<\/p>\n The CDC also noted that BA.2.86 variant poses a “low” public health risk.<\/p>\n But the CDC data<\/a><\/ins> released Monday did show that emergency department visits linked to COVID-19<\/a> have begun to climb nationwide.<\/p>\n One particular descendant of BA.2.86 might be driving the increase, experts say.<\/p>\n In recent weeks, scientists have been studying a steep increase in a BA.2.86 descendant called JN.1, which has become the fastest-growing subvariant worldwide<\/a><\/ins>. <\/p>\n “Currently, JN.1 is the most common version of BA.2.86 in the U.S. CDC projects BA.2.86 and its offshoots like JN.1 will continue to increase as a proportion of SARS-CoV-2 genomic sequences,” CDC spokesperson Jasmine Reed<\/a> told CBS News<\/em>.<\/p>\n The good news?<\/p>\n This season’s vaccines are expected to work against JN.1, as they do against BA.2.86, the agency said.<\/p>\n Disclaimer:<\/strong> Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.<\/p>\n \u00a9 2023 HealthDay. All rights reserved.<\/p>\n<\/div>\n Posted November 2023<\/p>\n Whatever your topic of interest, subscribe to our newsletters<\/a> to get the best of Drugs.com in your inbox.<\/p>\n Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 28, 2023. By Robin Foster HealthDay Reporter TUESDAY, Nov. 28, 2023 (Healthday News) — The prevalence of a highly mutated COVID variant has tripled in the past two weeks, new government data shows. Now, nearly 1 in 10 new COVID cases are fueled by the […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":362701,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/362698"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=362698"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/362698\/revisions"}],"predecessor-version":[{"id":362700,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/362698\/revisions\/362700"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/362701"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=362698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=362698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=362698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Sources<\/h2>\n
\n
<\/p>\n
Further Support and Information on COVID-19<\/h3>\n<\/p><\/div>\n
Read this next<\/h2>\n<\/div>\n
More news resources<\/h2>\n
Subscribe to our newsletter<\/h2>\n
\n